All enrolled sufferers who obtained no less than a person dose of zosuquidar or placebo throughout induction were monitored for the incidence of adverse gatherings (439 sufferers, 219 on zosuquidar and 210 on placebo). The most common adverse occasions were related to the duration of prolonged and substantial myelosuppression as https://enricob222nyj4.thenerdsblog.com/profile